Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.460
-0.080 (-5.19%)
Dec 5, 2025, 4:00 PM EST - Market closed
Calidi Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 11 | 22 | 54 | 100 | 282 | - |
| Market Cap Growth | -76.95% | -58.52% | -46.69% | -64.38% | - | - |
| Enterprise Value | 4 | 30 | 53 | - | - | - |
| Last Close Price | 1.46 | 13.80 | 181.21 | 1220.45 | 1177.25 | - |
| PS Ratio | - | - | - | 2232.42 | 628.14 | - |
| PB Ratio | 1.49 | 11.29 | -6.50 | -2.46 | -12.47 | - |
| P/TBV Ratio | 1.54 | 14.48 | - | - | - | - |
| Debt / Equity Ratio | 0.46 | 3.58 | -0.88 | -0.15 | -0.23 | -0.87 |
| Asset Turnover | - | - | - | 0.02 | 0.17 | - |
| Quick Ratio | 2.00 | 1.01 | 0.19 | 0.01 | 0.08 | 0.05 |
| Current Ratio | 2.12 | 1.08 | 0.42 | 0.02 | 0.11 | 0.06 |
| Return on Assets (ROA) | -119.65% | -112.47% | -287.25% | -482.80% | -229.02% | - |
| Return on Capital (ROIC) | -254.37% | -340.04% | - | - | - | - |
| Return on Capital Employed (ROCE) | -224.10% | -464.70% | 13611.30% | 57.30% | 42.60% | 96.30% |
| Earnings Yield | -239.80% | -99.68% | -54.56% | -25.31% | -3.88% | - |
| FCF Yield | -203.75% | -88.73% | -51.48% | -13.58% | -2.83% | - |
| Buyback Yield / Dilution | -571.35% | -374.79% | -98.24% | 56.93% | -15.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.